Merck & Co. Picks Up Exclusive Option on Xenon CV Drugs
Genetic Engineering News
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
- Abbott Laboratories
- AC Immune
- Angiochem
- AstraZeneca
- BioDelivery Sciences
- Biogen Idec
- Bionomics
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Celgene
- Enanta
- Endo
- Endocyte
- Forma Therapeutics
- Galapagos
- Genentech
- Genmab
- GSK
- Inhibrx Thrombogenics
- Ironwood
- Isis Pharmaceuticals
- Janssen
- LEO Pharma
- licensing
- MannKind
- Merck
- Merck KGaA
- Novartis
- Threshold Pharmaceuticals
- Tolero Pharmaceuticals
- Virobay
- Xenon